Results 121 to 130 of about 6,725 (159)

Niraparib

Reactions Weekly
  +12 more sources

Niraparib

Reactions Weekly, 2022
  +4 more sources

Niraparib

Reactions Weekly, 2023
  +4 more sources

Niraparib

Reactions Weekly, 2021
  +4 more sources

Niraparib

Reactions Weekly, 2019
  +4 more sources

Niraparib Maintenance Therapy in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Using an Individualized Starting Dose (NORA): A Randomized, Double-Blind, Placebo-Controlled Phase III Trial☆

Annals of Oncology, 2021
L Y Wu, M R Mírzá, J X Yang
exaly  

Niraparib Plus Abiraterone Acetate With Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer and Homologous Recombination Repair Gene Alterations: Second Interim Analysis of the Randomized Phase III MAGNITUDE Trial☆

Annals of Oncology, 2023
E J Small, K N Chi, K N Chi
exaly  

Niraparib With Androgen Receptor-Axis-Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: Safety and Pharmacokinetic Results From a Phase 1b Study (BEDIVERE)

Cancer Chemotherapy and Pharmacology, 2021
Edwin M Posadas, Fred Saad, Byron M Espina   +2 more
exaly  

Niraparib/olaparib

Reactions Weekly, 2023
  +4 more sources

P-Glycoprotein (ABCB1/MDR1) Controls Brain Penetration and Intestinal Disposition of the PARP1/2 Inhibitor Niraparib

Molecular Pharmaceutics, 2021
Alfred H Schinkel, Margarida L F Martins, Jos Beijnen   +2 more
exaly